Parent-Reported Symptoms and Perceived Effectiveness of Treatment in Children Hospitalized with Advanced Heart Disease - 23/10/21

Abstract |
Objective |
To characterize parent-reported symptom burden and effectiveness of symptom management in children hospitalized with advanced heart disease.
Study design |
Prospective survey study of 161 parents whose child was admitted to a single institution with advanced heart disease between March 2018 and February 2019 using the Survey about Caring for Children with Heart Disease.
Results |
Of the 161 patients, 54% were under 2 years old with a diagnosis of single ventricle physiology (39%), pulmonary hypertension (12%), and other congenital heart disease (28%). Over one-half (56%) of parents reported that their child was experiencing a high degree (“a great deal”/“a lot”) of symptoms. The most frequently reported symptoms were pain (68%), fatigue (63%), and breathing difficulties (60%). Of the symptoms that were treated, parents perceived successful treatment to be least likely for their child's sleep disturbance (24%), depression (29%), and fatigue (35%). Parents who reported their child's functional status as New York Heart Association class III/IV were more likely to report that their child was experiencing “a great deal” of symptoms, compared with those who reported class I/II (51% vs 19%, P < .001). Parents who reported their child was experiencing a high degree of suffering from fatigue were also more likely to report a high symptom burden (P < .001).
Conclusions |
Parents of children with advanced heart disease reported high symptom burden with a broad spectrum of symptoms. Parents reported fatigue and psychiatric symptoms frequently and rarely reported treatment as successful. Parents' view of their child's symptom burden was concordant with their perception of their child's functional status.
Le texte complet de cet article est disponible en PDF.Keywords : congenital heart disease, children, pediatric, patient reported outcomes, symptoms, heart failure, cardiomyopathy, fatigue
Abbreviations : HRQOL, I, II, III, IV
Plan
| Supported by the Advanced Cardiac Therapies Research and Education Fund, the Joseph Middlemiss Big Heart Foundation, and the Dorothy and Howard Dulman Fund. The authors declare no conflicts of interest. |
Vol 238
P. 221 - novembre 2021 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?
